Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

FDA access programmes shaved up to a year off drug approval times, new study shows

December 7, 2017
Research and Development, Sales and Marketing FDA, market access, pharma

A research letter published this week has suggested that the FDA initiatives to accelerate drug approvals in the US could …

News
dna-163466

Getting precision treatments over the line will be a team effort, not an individual bolt for glory

December 7, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Prostate Cancer UK, biotech, drugs, pharma, pharmaceutical, prostate cancer

We’ve finally reached the starter’s block when it comes to precision medicine approaches to prostate cancer, but Dr Matthew Hobbs, …

Feature
novartislr

Novartis Kisqali improves PFS in younger women

December 7, 2017
Research and Development Kisqali, Novartis, biotech, drugs, pharma, pharmaceutical

A Phase 3 trial looking at the use of Kisqali (ribociclib) to treat premenopausal or perimenopausal women with hormone-receptor positive, …

News
roche__tree

Roche’s haemophilia A drug shows meaningful bleed control in P3

December 7, 2017
Research and Development Roche, haemophilia, pharma

Roche has unveiled new Phase 3 data for its haemophilia A treatment Helimbra (emicizumab) in patients over 12 years of …

News

Old anti-drinking drug shows potential as cancer treatment

December 7, 2017
Research and Development Cancer, biotech, drugs, oncology, pharma, pharmaceutical

Disulfiram has been known as an anti-drinking compound for nearly seven decades. Initially, the compound was used in the vulcanisation …

News
Drug R&D

Clinical trial transparency research reveals progress, but more to be done

December 7, 2017
Medical Communications biotech, clinical trials, drugs, pharma, pharmaceutical

Bioethics international, a non-profit organisation, has published its second annual index ranking pharma companies by the transparency of data from …

News
shutterstock

Galectin Therapeutics’ share value plummets by half after NASH drug failure

December 6, 2017
Research and Development Galectin Therapeutics, nash, pharma, trial failure

Galectin Therapeutics has seen its share value almost halve after its revealed that GR-MD-02, its experimental treatment for non-alcoholic steatohepatitis …

News
news_accc

Two big pharma companies accused of false marketing

December 6, 2017
Research and Development, Sales and Marketing GSK, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis and GSK have been taken to court by the Australian Competition and Consumer Commission (ACCC) over allegations of falsely …

News
gsk_wall

GSK commits to multi-million investment in UK life sciences sector deal

December 6, 2017
Research and Development, Sales and Marketing GSK, biotech, drugs, pharma, pharmaceutical

In the latest boost to the UK’s life sciences strategy, GSK has committed £40 million to its work identifying new …

News
novartis_window

Novartis nets first acute myeloid leukaemia approval in Canada, but NICE says no

December 6, 2017
Research and Development, Sales and Marketing Canada, NICE, Novartis, Rydapt, UK, acute myeloid leukaemia, leukaemia, pharma

Novartis is celebrating the news that its drug Rydapt (midostaurin) has been awarded marketing approval in Canada for the treatment …

News
aaeaaqaaaaaaaadzaaaajda2mmvkoduzltaxndctngywns1iztq3lwm3mtg3mzk0njnkyw

Veeva launches upgrade to Veeva CRM Engage

December 6, 2017
Medical Communications Zinc systems, biotech, drugs, pharma, pharmaceutical, veeva

Veeva took the opportunity at its European Commercial & Medical Summit to reveal the latest upgrade to its Veeva CRM …

News
diabetes-2424105_960_720

Study reveals diet able to reverse diabetes in half of patients

December 6, 2017
Research and Development biotech, diabetes, drugs, pharma, pharmaceutical

Building on their previous research emerging from Professor Roy Taylor’s work at Newcastle University, a study has found that 45.6% …

News
novo_flag

Novo Nordisk unveils hard-hitting data for two of its diabetes therapies

December 5, 2017
Manufacturing and Production, Research and Development Novo Nordisk, Tresiba, Xultophy, diabetes, pharma

Novo Nordisk has lifted the curtain on new data from two of its therapies for diabetes, Xultophy (insulin degludec/liraglutide) and …

News
vanilla-flower-542019_960_720

Vanilla compound found to prevent psoriasis

December 5, 2017
Manufacturing and Production, Research and Development biotech, drugs, pharma, pharmaceutical, psoriasis, vanilla

Psoriasis is a big pharmaceutical market, it’s the most common autoimmune disease in the US and as many as 7.5 …

News
nhs_sign

NHS talking therapies for mental health hit a high with 1.4 million referrals

December 5, 2017
Manufacturing and Production, Medical Communications NHS, anxiety, depression, mental illness, pharma

New data has revealed that the number of UK patients seeking talking therapies on the NHS is on the rise, …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026